These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26962268)

  • 1. Drug Design Strategies for GPCR Allosteric Modulators.
    Conn PJ; Kuduk SD; Doller D
    Annu Rep Med Chem; 2012; 47():441-457. PubMed ID: 26962268
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrated Multi-Class Classification and Prediction of GPCR Allosteric Modulators by Machine Learning Intelligence.
    Hou T; Bian Y; McGuire T; Xie XQ
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pharmacological effect of allosteric regulation at GPCR heterodimer].
    Zhang N; Chen J; Gong L; Liu LL; Bai B
    Sheng Li Ke Xue Jin Zhan; 2013 Apr; 44(2):93-8. PubMed ID: 23847918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu
    Hellyer SD; Albold S; Wang T; Chen ANY; May LT; Leach K; Gregory KJ
    Mol Pharmacol; 2018 May; 93(5):504-514. PubMed ID: 29514854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation of G protein-coupled receptor signaling.
    Shen S; Zhao C; Wu C; Sun S; Li Z; Yan W; Shao Z
    Front Endocrinol (Lausanne); 2023; 14():1137604. PubMed ID: 36875468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5.
    Bian Y; Feng Z; Yang P; Xie XQ
    AAPS J; 2017 Jul; 19(4):1235-1248. PubMed ID: 28560482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
    Slosky LM; Caron MG; Barak LS
    Trends Pharmacol Sci; 2021 Apr; 42(4):283-299. PubMed ID: 33581873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
    Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.
    Leach K; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2007 Aug; 28(8):382-9. PubMed ID: 17629965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.
    Lindsley CW; Emmitte KA; Hopkins CR; Bridges TM; Gregory KJ; Niswender CM; Conn PJ
    Chem Rev; 2016 Jun; 116(11):6707-41. PubMed ID: 26882314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clickable Photoaffinity Ligands for Metabotropic Glutamate Receptor 5 Based on Select Acetylenic Negative Allosteric Modulators.
    Gregory KJ; Velagaleti R; Thal DM; Brady RM; Christopoulos A; Conn PJ; Lapinsky DJ
    ACS Chem Biol; 2016 Jul; 11(7):1870-9. PubMed ID: 27115427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of water and protein flexibility in the structure-based virtual screening of allosteric GPCR modulators: an mGlu
    Orgován Z; Ferenczy GG; Keserű GM
    J Comput Aided Mol Des; 2019 Sep; 33(9):787-797. PubMed ID: 31542869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery.
    Bian Y; Jun JJ; Cuyler J; Xie XQ
    Eur J Med Chem; 2020 Nov; 206():112690. PubMed ID: 32818870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.